Much-anticipated Ebola vaccine efficacy trial starts
This article was originally published in Scrip
Executive Summary
A much-anticipated trial taking place in and around Monrovia, Liberia testing the effectiveness of two experimental Ebola vaccines has started in earnest, the US National Institute of Allergy and Infectious Diseases (NIAID) said on 2 February – confirming the news West African government officials had announced.